Mark Fridlyand - Director, Strategy & Corporate Development

Por um escritor misterioso

Descrição

Mark Fridlyand - Director, Strategy & Corporate Development
Genentech: Mark Merchant Senior Director, Translational Oncology
Mark Fridlyand - Director, Strategy & Corporate Development
Nuclear Odontogenic Ameloblast-Associated Protein (ODAM) Correlates with Melanoma Sentinel Lymph Node Metastasis
Mark Fridlyand - Director, Strategy & Corporate Development
2022
Mark Fridlyand - Director, Strategy & Corporate Development
img_003.jpg
Mark Fridlyand - Director, Strategy & Corporate Development
PDF) Drug Target Identification in Triple Negative Breast Cancer Stem Cell Pathways: A Computational Study of Gene Regulatory Pathways Using Boolean Networks
Mark Fridlyand - Director, Strategy & Corporate Development
Personalised medicine for the European Citizen
Mark Fridlyand - Director, Strategy & Corporate Development
Mark Fridlyand - Director, Strategy & Corporate Development - Synonym
Mark Fridlyand - Director, Strategy & Corporate Development
Alex Fridlyand email address & phone number Newlight Partners Partner contact information - RocketReach
Mark Fridlyand - Director, Strategy & Corporate Development
Journal of Cellular Physiology, Cell Biology Journal
Mark Fridlyand - Director, Strategy & Corporate Development
Edward Shenderovich - Co-founder & CEO at Synonym Biotechnologies
Mark Fridlyand - Director, Strategy & Corporate Development
Bayesian metamodeling of complex biological systems across varying representations
Mark Fridlyand - Director, Strategy & Corporate Development
Mark Fridlyand - Senior Database Developer - Intercontinental Exchange
de por adulto (o preço varia de acordo com o tamanho do grupo)